Bill > S3278

This bill expands the authority of Emergency Medical Technicians (EMTs) to administer glucagon, a medication used to treat dangerously low blood sugar (hypoglycemia) in individuals with diabetes, and to perform blood glucose tests. The Commissioner of Health will establish written standards, protocols, or application procedures for EMTs to become authorized to independently administer glucagon, which can come in various forms like nasal spray or auto-injectors, and to conduct blood glucose tests. This authorization may include training on authorized forms of glucagon administration, at a minimum including auto-injector devices. The Commissioner can modify, suspend, or terminate an EMT's authorization if necessary for public health or safety and may require EMTs to transfer patients to a hospital unless refused. The Commissioner will maintain a registry of authorized EMTs and may annually publish a list of those authorized to administer glucagon and blood glucose tests, which will be publicly available. Fees may be charged for training and testing if not covered by the "Emergency Medical Technician Training Fund." The act will take effect six months after it is enacted.

Health and Social Services

https://www.njleg.state.nj.us/bill-search/2024/S3278